Novartis AG entered a landmark collaboration with Cleara Biotech worth up to EUR 280 million in November 2025
It belongs to the same broader copper-peptide area as GHK-Cu, but the peptide sequence is different, so it works best as its own reference material rather than a direct substitute
Migraines usually arent known as side effects
It represents a fundamentally different approach to metabolic intervention, one that addresses energy expenditure in addition to energy intake
As investigations and stomach paralysis weight loss drugs lawsuits progress, it is critical for everyone, like consumers, healthcare providers and legal professionals, to stay informed about these developments
Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma